Recent Updates
Recently added Catalysts
CGEM Positive Sentiment Score: 70/100

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Monday, February 24, 2025 1 min read
Key Takeaway: Cullinan Therapeutics, a biopharmaceutical company, has announced its participation in upcoming investor conferences. The Chief Executive Officer, Nadim Ahmed, and Chief Medical Officer, Jeffrey Jones, will engage with investors at the TD Cowen 45th Annual Health Care Conference in Boston and the Leerink Partners Global Healthcare Conference in Miami Beach. The company aims to provide insights into its targeted therapies and developments during these events. Webcasts of the discussions will be available for interested parties through their investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cullinan Therapeutics is actively engaging with investors through multiple conferences.
  • Key executives will share insights about the company's strategies and developments.
  • The presence in prominent conferences indicates strong interest in the company's pipeline.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston, MA on Tuesday, March 4, 2025, at 11:10 a.m. ET.
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025, at 11:20 a.m. ET.
Webcasts of the fireside chats will be available under the Events and Presentations section of the Company’s investor relations website at https://cullinantherapeutics.com/events-and-presentations/.
About Cullinan Therapeutics
nsmith@cullinantx.com
rweldon@cullinantx.com

Frequently Asked Questions

When is Cullinan's fireside chat at the TD Cowen Conference?

The fireside chat is on March 4, 2025, at 11:10 a.m. ET.

Which conferences will Cullinan Therapeutics attend?

Cullinan will participate in the TD Cowen and Leerink Partners conferences.

Where can I find Cullinan's conference webcasts?

Webcasts are available on the investor relations website under Events and Presentations.

Who will speak at Cullinan's fireside chats?

Nadim Ahmed and Dr. Jeffrey Jones will be the speakers.

When is Cullinan's fireside chat at the Leerink Partners Conference?

It is scheduled for March 11, 2025, at 11:20 a.m. ET.

Tags: CGEM Viatris Investor Conferences Healthcare Cullinan Therapeutics investor conferences biopharmaceuticals Nadim Ahmed
Last updated: Feb 24, 2025